Skip to content
中文产业新闻评分61Chinese source

阿斯利康20亿美元入股Summit Therapeutics,认购可转换优先股

阿斯利康“小赌怡情”,Summit盼来强援

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.